The new prefilled syringe has the same composition but removes the need for reconstitution. The Food and Drug Administration (FDA) has accepted for review the regulatory application for a new ...

Evidence from a team of scientists at the University of Oxford indicates that the newer shingles vaccine is more protective against dementia compared to the previous shingles vaccine. Both shingles ...

The large-scale study is one of the first to evaluate the two-dose recombinant zoster vaccine (Shingrix) in a large sample group. Previous research has shown that dementia risk is lower with the ...

(RTTNews) - British drug maker GSK plc (GSK, GSK.L) announced Friday that the US Food and Drug Administration has accepted for review the regulatory application of a prefilled syringe presentation of ...

After the rofecoxib (Vioxx) withdrawal in 2004 made painfully clear how much harm a passive reporting system can miss, ...

Trial met primary endpoint, non-inferior immune response for both vaccines when co-administered compared with separate administration Co-administration of the RSV and shingles adjuvanted vaccines was ...

Shingrix (recombinant varicella-zoster virus) is a brand-name vaccine used to help prevent herpes zoster (shingles) infection in certain adults. Shingrix is not known to interact with other ...

GlaxoSmithKline, the maker of the shingles vaccine Shingrix that has been in short supply, told customers Jan. 10 that more shipments of the vaccine are on the way to U.S. pharmacies, according to ...